NUREG-0825: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (StriderTol Bot change) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
Line 1: | Line 1: | ||
#REDIRECT [[NUREG-0825, | #REDIRECT [[NUREG-0825, Summary of 860806-14 Meetings W/Util,Lll,Eg&G & Cygna Corp in San Francisco,Ca Re Resolution of SEP (NUREG-0825) Reevaluation.Unresolved Issues,Performance of Audits & case-by-case Reviews & Confirmatory Analysis Discussed]] |